These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1539 related items for PubMed ID: 15936549

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer.
    Zelefsky MJ, Levin EJ, Hunt M, Yamada Y, Shippy AM, Jackson A, Amols HI.
    Int J Radiat Oncol Biol Phys; 2008 Mar 15; 70(4):1124-9. PubMed ID: 18313526
    [Abstract] [Full Text] [Related]

  • 24. Acute genitourinary toxicity after high dose rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: Second analysis to determine the correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T, Katoh H, Noda SE, Ito K, Yamamoto T, Kashiwagi B, Nakano T.
    Int J Radiat Oncol Biol Phys; 2005 Oct 01; 63(2):472-8. PubMed ID: 16168839
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A, Morris M, Schmidt-Ullrich R, Wu Q, Mohan R, Abayomi O, Buck D, Holdford D, Dawson K, Dinardo L, Reiter E.
    Int J Radiat Oncol Biol Phys; 2004 Oct 01; 60(2):374-87. PubMed ID: 15380569
    [Abstract] [Full Text] [Related]

  • 28. Intensity-modulated radiotherapy as primary treatment for prostate cancer: acute toxicity in 114 patients.
    De Meerleer G, Vakaet L, Meersschout S, Villeirs G, Verbaeys A, Oosterlinck W, De Neve W.
    Int J Radiat Oncol Biol Phys; 2004 Nov 01; 60(3):777-87. PubMed ID: 15465194
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Gastro-intestinal and genito-urinary morbidity after 3D conformal radiotherapy of prostate cancer: observations of a randomized trial.
    Koper PC, Jansen P, van Putten W, van Os M, Wijnmaalen AJ, Lebesque JV, Levendag PC.
    Radiother Oncol; 2004 Oct 01; 73(1):1-9. PubMed ID: 15465140
    [Abstract] [Full Text] [Related]

  • 31. Hypofractionated boost to the dominant tumor region with intensity modulated stereotactic radiotherapy for prostate cancer: a sequential dose escalation pilot study.
    Miralbell R, Mollà M, Rouzaud M, Hidalgo A, Toscas JI, Lozano J, Sanz S, Ares C, Jorcano S, Linero D, Escudé L.
    Int J Radiat Oncol Biol Phys; 2010 Sep 01; 78(1):50-7. PubMed ID: 19910135
    [Abstract] [Full Text] [Related]

  • 32. Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: the combined experience of nine institutions in patients treated in 1994 and 1995.
    Kupelian P, Kuban D, Thames H, Levy L, Horwitz E, Martinez A, Michalski J, Pisansky T, Sandler H, Shipley W, Zelefsky M, Zietman A.
    Int J Radiat Oncol Biol Phys; 2005 Feb 01; 61(2):415-9. PubMed ID: 15667961
    [Abstract] [Full Text] [Related]

  • 33. Stereotactic body radiotherapy for localized prostate cancer: interim results of a prospective phase II clinical trial.
    King CR, Brooks JD, Gill H, Pawlicki T, Cotrutz C, Presti JC.
    Int J Radiat Oncol Biol Phys; 2009 Mar 15; 73(4):1043-8. PubMed ID: 18755555
    [Abstract] [Full Text] [Related]

  • 34. Combined brachytherapy with external beam radiotherapy for localized prostate cancer: reduced morbidity with an intraoperative brachytherapy planning technique and supplemental intensity-modulated radiation therapy.
    Zelefsky MJ, Nedelka MA, Arican ZL, Yamada Y, Cohen GN, Shippy AM, Park JJ, Zaider M.
    Brachytherapy; 2008 Mar 15; 7(1):1-6. PubMed ID: 18299108
    [Abstract] [Full Text] [Related]

  • 35. Clinical results of combined treatment conformal high-dose-rate iridium-192 brachytherapy and external beam radiotherapy using staging lymphadenectomy for localized prostate cancer.
    Hiratsuka J, Jo Y, Yoshida K, Nagase N, Fujisawa M, Imajo Y.
    Int J Radiat Oncol Biol Phys; 2004 Jul 01; 59(3):684-90. PubMed ID: 15183471
    [Abstract] [Full Text] [Related]

  • 36. [Conformal radiotherapy for patients with clinical stage T1-T3 prostate cancer].
    Majewski W, Miszczyk L, Zajusz A.
    Przegl Lek; 2004 Jul 01; 61(5):503-8. PubMed ID: 15515815
    [Abstract] [Full Text] [Related]

  • 37. Evaluation of the dosimetric impact of non-exclusion of the rectum from the boost PTV in IMRT treatment plans for prostate cancer patients.
    Kassim I, Dirkx ML, Heijmen BJ.
    Radiother Oncol; 2009 Jul 01; 92(1):62-7. PubMed ID: 19278745
    [Abstract] [Full Text] [Related]

  • 38. [Three-dimensional conformal radiation therapy for prostate cancer in Hamamatsu Medical Center].
    Kanda T, Nakagomi K, Goto S, Iijima M.
    Hinyokika Kiyo; 2007 Jan 01; 53(1):9-12. PubMed ID: 17310762
    [Abstract] [Full Text] [Related]

  • 39. Late outcomes following hypofractionated conformal radiotherapy vs. standard fractionation for localized prostate cancer: a nonrandomized contemporary comparison.
    Leborgne F, Fowler J.
    Int J Radiat Oncol Biol Phys; 2009 Aug 01; 74(5):1441-6. PubMed ID: 19395194
    [Abstract] [Full Text] [Related]

  • 40. Late gastrointestinal morbidity after three-dimensional conformal radiation therapy for prostate cancer fades with time in contrast to genitourinary morbidity.
    Karlsdóttir A, Muren LP, Wentzel-Larsen T, Dahl O.
    Int J Radiat Oncol Biol Phys; 2008 Apr 01; 70(5):1478-86. PubMed ID: 18060703
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 77.